Appropriate Dose of Neostigmine for Reversal of Rocuronium and Cisatracurium
Clinical trial NCT01885715 · COMPLETED
Trial details
- NCT number
- NCT01885715
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-06-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.